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Trypanosome infections are marked by severe pathological features, including anemia, splenomegaly, and
suppression of T-cell proliferation. We have used lymphotoxin--deficient (LT-/) mice, as well as LT-–
tumor necrosis factor-double-deficient (LT-/ TNF/) mice, to analyze the contributions of these related
cytokines in both induction of trypanosomosis-associated immunopathology and infection control. Moreover,
as the cytokine-deficient mice used have no detectable lymph nodes and lack germinal-center formation upon
immune stimulation, we have analyzed the functional importance of both the lymph nodes and spleen during
experimental Trypanosoma brucei infections. First, we show that the absence of LT- does not significantly alter
early trypanosomosis development or pathology but does result in better control of late-stage parasitemia
levels and slightly prolonged survival. This increased survival of infected LT-/ mice coincides with the
appearance of increased chronic-stage anti-trypanosome immunoglobulin M (IgM)-IgG2a serum titers that
are generated in the absence of functional peripheral lymphoid tissue and do not require germinal-center
formation. Second, we show that splenectomized mice control their parasitemia to the same extent as fully
immune-competent littermates. Finally, using LT-/ TNF/ double-deficient mice, we show that in these
mice T. brucei infections are very well controlled during the chronic infection stage and that infection-induced
pathology is minimized. Together, these findings indicate that while increased IgM-IgG2a anti-trypanosome
antibody titers (generated in the absence of LT-, peripheral lymph nodes, and germinal-center formation)
coincide with improved parasitemia control, it is TNF that has a major impact on trypanosomosis-associated
immunopathology.
African trypanosomes are extracellular parasitic protozoa
transmitted by the bite of the tsetse fly (38). In order to com-
plete their life cycle, trypanosomes require an obligatory de-
velopmental step in a mammalian host. Consequently, these
parasites have to cope with the host immune system and es-
tablish a state of equilibrated growth regulation ensuring op-
timal survival and effective transmission. First, African try-
panosomes escape from immune recognition through the
mechanism of antigenic variation of their variant-specific sur-
face glycoprotein (VSG), the major surface antigen that acts as
an ever-changing protective coat for the parasite (4). Besides
this active VSG-based defense system, trypanosomes also may
utilize host immunomodulatory molecules and networks to
regulate their development. Indeed, in different experimental
trypanosome infections, modifications of T-cell and macro-
phage responsiveness were reported to occur in lymph nodes,
spleen, and bone marrow (5, 16, 34). In addition, impairment
of the antigen presentation capacity of macrophages (27) and
the induction of polyclonal B-cell stimulation (2) occurs. At the
level of infection-associated cytokine secretion, induction of
gamma interferon (IFN-) and tumor necrosis factor (TNF)
has been extensively documented as well (7, 13, 21). These type
1 cytokines have been described as playing an important dual
role in trypanosomosis, being involved both in the induction of
host pathology and in parasite control. Indeed, while IFN-
has been accepted as playing a major role in infection-associ-
ated T-cell suppression in the lymph nodes (3), IFN--deficient
mice suffer from accelerated parasite growth and exhibit a
significantly reduced survival time when infected with African
trypanosomes (13). In the case of TNF, a role in trypanoso-
mosis-associated immunopathology has been suggested in sev-
eral studies, showing (i) the enhanced expression of TNF in the
brains of Trypanosoma brucei-infected mice (14), (ii) the asso-
ciation between TNF production by monocytes and the sever-
ity of disease-associated anemia in trypanosome-infected cattle
(36), (iii) the correlation between serum TNF levels and neu-
ropathological symptoms in human sleeping sickness patients
(30), and (iv) the involvement of TNF in trypanosome-elicited
immunosuppression and overall morbidity (20). On the other
hand, TNF also exerts a direct influence on the control of
parasite survival through its trypanolytic effect (6, 22). The
overall influence of TNF on the outcome of experimental try-
panosome infections has been studied, using TNF-deficient
mice (20). As expected, these mice exhibited significantly in-
creased parasitemia but showed at the same time strongly
reduced infection-associated pathology. In addition, the capac-
ity to clear successive parasitemia peaks was found to be un-
altered and corresponded to an unaltered overall anti-VSG
antibody induction pattern in infected TNF/ mice. It is in-
teresting, with respect to the biological functions of TNF, that
the TNF-related cytokine lymphotoxin- (LT-) was found to
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have no direct antitrypanosomal activity at all (19). Although
TNF and LT- have high amino acid sequence homology (28)
and both bind to the TNF p55 and p75 receptors as soluble
homotrimers (37), alterations in the TIP sequences of both
molecules result in TNF exerting a lectin-like affinity for sev-
eral carbohydrate sequences while LT- does not (19). There-
fore, in the present study we have extended the analysis of the
role of the TNF family cytokines by investigating trypanoso-
mosis development and the occurrence of infection-associated
pathology in both LT--deficient and LT-–TNF-double-defi-
cient mice. It is important to note here that LT- is crucial for
peripheral lymphoid organ development and segregation of B
and T cells in the spleen. As a result, LT--deficient mice lack
peripheral lymph nodes as well as germinal-center formation
upon stimulation with T-cell-dependent antigens (9). In the
study presented here, our data show that in the absence of
LT-, increased serum titers of anti-VSG immunoglobulin M
(IgM) and IgG2a antibodies occurred during the chronic phase
of experimental trypanosome infections, coinciding with an
improved parasitemia control and slightly but significantly pro-
longed survival. In addition, our results show that LT-–TNF-
double-deficient mice also control the chronic infection phase
very efficiently and have an even more prolonged survival time
than the LT--deficient mice, due to the virtual absence of
infection-induced immunopathology. Thus, together these re-
sults suggest that while LT--independent and germinal-cen-
ter-independent generation of anti-VSG IgM-IgG2a antibod-
ies coincides with improved parasitemia control, excessive
TNF production is the main cause of trypnosomosis-associated
immunopathology and early death of infected wild-type (WT)
mice.
MATERIALS AND METHODS
Mice. Homozygous B6,129S-Ltatm1Dch (B6,129S) female LT--deficient
mice (9), 8 weeks of age, as well as 8-week-old female control hybrid F2 C57BL/
6Jx129S3/SvImJ (B6129SF2) mice and control inbred C57BL/6J and 129SvImJ
mice, were obtained from the Jackson Laboratories. The homozygous 8-week-
old B6,129S LT-–TNF-double-deficient mice (10) came from a laboratory
breeding colony.
Parasites and analysis of parasitemia. All experimental trypanosome infec-
tions were performed by intraperitoneal inoculation of 5,000 living pleomorphic
Trypanosoma brucei brucei AnTat 1.1E parasites and were repeated at least two
times. Using 10 mice per experimental group, we followed parasitemia develop-
ment in all mice individually by regular microscopic analysis of a 1/100-diluted
blood sample taken from the tip of the tail. Occurrence of anemia was followed
by red blood cell (RBC) counts of the same sample. For the analysis of infection-
induced splenomegaly, three additional mice were infected and individually
sacrificed on days 7, 14, and 28 for spleen weight analysis, as was one noninfected
control mouse on day 0. Spleen weights from animals that were killed just prior
to the lethal end of the infection were recorded as well.
Serum cytokine analysis. Sera from infected animals were collected on days 0,
7, 14, and 28 and just prior to the lethal end of the infection of the mice used for
parasitemia analysis.The sera were first stored at 80°C and later screened in
batches for their TNF and IFN- contents, using commercially available Cyto-
Sets enzyme-linked immunosorbent assay (ELISA) systems from Biosource. The
ELISAs were performed according to the producer’s guidelines, and a strepta-
vidin-horseradish peroxidase detection system was used to reveal the results.
Detection limits for both systems ranged from 15 to 2,000 pg/ml, using serum
samples that were diluted 1/4 in sample solution.
Anti-VSG and anti-trypanosome serum antibody titer determination. For the
determination of anti-VSG and anti-trypanosome serum antibody titers, first,
purified soluble VSG (sVSG) and total soluble trypanosome extracts were pre-
pared. For preparation of VSG, pleomorphic T. b. brucei AnTat 1.1E parasites
were isolated at the peak of their parasitemia and separated from RBCs on a
DEAE52 cation-exchange column equilibrated at pH 8.0 with phosphate-buff-
ered saline supplemented with 16 g of glucose/liter (18). sVSG was obtained
through osmotic lysis of trypanosomes by 30 min of incubation at 4°C in 125 mM
NaH2PO4 (pH 5.5) (109 cells/ml) followed by a 5-min incubation at 37°C in 10
mM sodium phosphate (pH 8.0). The supernatant was passed through a column
of DEAE52 equilibrated in 10 mM sodium phosphate (pH 8.0). Following a
change of buffer to 10 mM Tris (pH 8.1) on a G25 desalting column (Pharmacia),
sVSG was further purified by high-performance liquid chromatography (Akta;
Pharmacia) using a Resource Q anion-exchange column (Pharmacia) equili-
brated with 10 mM Tris (pH 8.1). A linear NaCl gradient reaching 100 mM was
used to elute VSG. The protein concentrations of the VSG were estimated with
a detergent-compatible protein assay kit (Bio-Rad Laboratories), using bovine
serum albumin as a standard. Total soluble extract of T. b. brucei trypanosomes
was obtained by three rounds of sonication of DEAE52-purified parasites, fol-
lowed by 10 min of centrifugation at 13,000 rpm in an Eppendorf centrifuge. The
supernatants were collected, and the total protein concentration was estimated
as for VSG.
For the determination of serum antibody titers, VSG and total soluble try-
panosome protein extract was used at concentrations of 2 and 5 g/ml, respec-
tively, to coat ELISA plates (Nunc). Sera from infected mice that were collected
on days 0, 7, 14, and 28 and just prior to the lethal end of the infection for
cytokine analysis were also used in these experiments. Serial 1/2 dilutions of all
sera were prepared starting from a concentration of 1/20. Endpoint titers in
serum were determined using the isotype-specific Cloningtype System-HRP from
Southern Biotechnology Associates, Inc.
RESULTS
T. b. brucei parasitemia development in LT--deficient mice.
We have previously reported that during experimental try-
panosome infections TNF plays a crucial role in both control of
parasitemia and induction of infection-associated pathology
(20). We have now extended our study by analyzing the role of
the TNF-related cytokine LT- in T. brucei infections.
Both B6,129S LT--deficient (LT-/) mice and B6129SF2
(WT) control mice were infected with the pleomorphic T. b.
brucei AnTat 1.1E strain by intraperitoneal inoculation with
5,000 living parasites. The results presented in Fig. 1A show
that both LT-/ and WT mice develop their first parasitemia
peak around day 7 and that the average peak parasitemia level
in both strains of mice reaches 2  108 parasites/ml of blood.
Following the peak, efficient parasite elimination occurs in
both strains, and the infection patterns remain similar and
controlled till about the fourth week of infection. During this
infection period, parasitemia levels remain below 108 para-
sites/ml of blood. During the fifth week of infection, para-
sitemia control is lost in the WT mice and parasite levels in the
blood increase exponentially. WT mice succumb to the infec-
tion with a median survival time of 38 days and with a parasite
load of more than 5 108/ml of blood. In contrast, parasitemia
levels in the LT-/ mice remain controlled for an increased
period of time, and median survival is slightly but significantly
extended to 45 days (P  0.003) (Fig. 1B).
As the LT-/ mice were generated on a mixed B6,129S
background, T. b. brucei AnTat 1.1E parasitemia development
was also analyzed in the C57BL/6J and 129SvImJ strains sep-
arately. Neither the pattern of infection nor the survival time of
infected mice from either strain was found to show any signif-
icant difference from that recorded in the B6129SF2 mice (Fig.
1C and D), the median survival time being 38 and 35 days for
the C57BL/6J and the 129SvImJ strains, respectively. This re-
sult could be important for future experimental T. brucei in-
fection studies, as a large collection of cytokine-deficient
mouse strains is available on a mixed B6,129S background.
T. b. brucei parasitemia development in TNF–LT--double-
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deficient mice. TNF and LT- are cytokines that belong to the
same family, show high sequence homology, and can both bind
as soluble trimers to the same receptors (37). However, the
outcome of T. brucei infections differs in some major aspects in
LT-/ mice compared to those in TNF/ mice. Indeed, in
T. b. brucei-infected TNF/ mice, no significant alteration in
survival time was recorded compared to WT mice, while a
significant effect on peak parasitemia control was observed
(Fig. 1E and F) (20). To further evaluate the relative contri-
butions of both cytokine genes, T. b. brucei infections were
analyzed in TNF/ LT-/ mice as well. As shown in Fig.
1G, parasitemia in the TNF/ LT-/ mice differs signifi-
cantly from that recorded in the control B6129SF2 WT mice.
During the first 2 weeks of the infection, two parasitemia peaks
occur in both strains, but parasite levels are higher in the
double-deficient mice than in the WT mice. After this acute
phase, TNF/ LT-/ mice efficiently control their infection
till day 62 of the infection, exhibiting mean parasitemia levels
that do not exceed 107 parasites/ml of blood. During the final
stage of the infection, parasitemia control is suddenly lost, and
the mice succumb to their infection with a mean survival time
of 71 days (Fig. 1H) and with an extremely high number of
parasites in the circulation. In contrast to the situation re-
corded in the TNF/ LT-/ double-deficient mice, para-
sitemia in the WT mice is not controlled after the second peak.
Mean parasitemia levels in these mice remain high and oscil-
late around 5  107. The mean survival time of infected WT
mice is only 39 days, i.e., 32 days shorter than the mean survival
time of mice that lack the LT- gene.
Trypanosomosis-associated immunopathology in LT--de-
ficient mice. Mice experimentally infected with African try-
panosomes manifest severe infection-associated anemia and
splenomegaly that most often coincides with a lack of locomo-
tor activity and deterioration of fur quality, finally resulting in
high overall morbidity. These pathological features were ana-
lyzed in trypanosome-infected LT-/, TNF/ LT-/,
and B6129SF2 WT mice. Induction of anemia was followed by
hematocytometric analysis of the blood samples isolated for
the parasitemia determination. As shown in Fig. 2A, in mice
that suffer from severe infection-associated immunopathology,
the occurrence of anemia becomes significant at day 8 of the
infection, coinciding with the parasite elimination that follows
the control of the first parasitemia peak. Within a 48-h period,
mean RBC counts drop to 34 and 45% for the LT-/ and
WT mice, respectively. From day 10 on, the RBC counts re-
cover slightly in both strains. In the case of the infection of WT
mice, however, severe anemia recurs from day 15 of the infec-
tion onwards, and RBC counts keep steadily dropping till the
end of the infection, resulting in an overall RBC count reduc-
tion of between 60 and 75% at the time of death. In contrast,
in the infected LT-/ mice, the RBC counts remain approx-
imately constant between day 10 and day 28 of the infection,
representing only moderate anemia. Afterwards, RBC counts
start to drop, finally reaching an average 52% reduction level
by the end of the infection.
In contrast to WT and LT-/ mice, TNF/ and TNF/
LT-/ mice suffer from only very mild trypanosomosis-as-
sociated pathology. The alterations in RBC counts in these
mice are presented in Fig. 2B. While mice from both strains
showed a slight reduction of RBCs during the 2 days that
follow clearance of the first parasitemia peak, all of the mice
recovered quickly from infection-associated anemia. Besides
the reduced anemia, the T. b. brucei-infected TNF/ LT-/
mice also lacked any other signs of immunopathology and
resembled the phenotype of T. brucei-infected TNF/ mice
that was reported previously (20). Just prior to the deaths of
the TNF/ LT-/ mice, infection-induced reduction of lo-
comotor activity was the only pathological feature that started
to become apparent. As mentioned above, death itself oc-
curred due to a so-far-unexplained sudden loss of parasite
growth control that resulted in exponential parasite prolifera-
tion. This feature is, however, characteristic of T. brucei para-
sitemia in all strains of mice studied and consequently cannot
be linked to the presence or absence of TNF or LT- during
the experimental infection.
Apart from the occurrence of infection-associated anemia,
the occurrence of splenomegaly was also followed in all groups
of T. b. brucei-infected mice (results not shown). For this pur-
pose, additional infected mice were sacrificed on days 0, 7, 14,
and 28 of the infection. In order to measure splenomegaly at
later time points, mice that were used for parasitemia deter-
mination were sacrificed when they reached the terminal stage
of the infection. The results obtained showed that splenomeg-
aly in all of the mice was already significant at day 7 of the
infection. A maximal spleen enlargement was observed around
day 14, with spleen weights showing up to a 15-fold increase
compared to the spleens of noninfected mice. These results
indicate that splenomegaly develops similarly in all strains and
consequently that neither infection-associated anemia nor par-
asitemia control is affected by the alterations in the spleen.
Trypanosomosis-associated induction of serum TNF and
IFN- in LT--deficient mice. Experimental T. b. brucei infec-
tions have been reported to be affected by both TNF and
IFN- (13, 19). Furthermore, it has been documented that
LT-/ mice are characterized by partially deficient TNF
production upon specific stimulation (1). Hence, we compared
circulating TNF and IFN- levels in T. b. brucei-infected LT-
-deficient and WT mice at different time points of the infec-
tion. The results presented in Fig. 2C show that upon infection
with African trypanosomes, both strains of mice respond with
FIG. 1. (A and B) Parasitemia development in LT--deficient mice compared to parasitemia development in control WT mice (A), as well as
survival of infected individual mice in both groups (B). p.i., postinfection. (C and D) For reference, parasitemia development in parental C56BL/6J
and 129SvImJ (129) mice is also shown (C), as well as the individual survival of these mice (D). (E to H) Parasitemia development (E) and survival
(F) of T. brucei-infected TNF-deficient and control (WT) mice (data from reference 20), as well as parasitemia development (G) and survival
(H) of infected LT-–TNF-double-deficient and WT mice, are shown. All results were obtained with experimental groups of 10 mice, and
individual experiments were repeated at least two times with similar results. Parasitemia data are presented as mean parasite counts (# Par.) per
milliliter of blood  standard deviations. In the experiment represented in panel H, one LT-–TNF-double-deficient mouse () died early on day
15 for unknown reasons. This mouse was not taken into account for the calculation of the mean survival time of the whole group.
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increased serum TNF levels. However, in particular during the
first stage of the infection, serum TNF levels measured in the
LT-/ mice remained significantly below those of infected
WT mice. On the other hand, towards the end of the infection,
serum TNF reached the same elevated levels in both strains.
As such, the combined results presented in Fig. 2A and C
indicate that in LT-/ mice infection-associated anemia, as
well as the coinciding signs of morbidity, seems to be corre-
lated with the levels of circulating TNF.
In contrast to the differential regulation of TNF production
during the early stage of infection in LT-/ and WT mice, no
differences were found in serum IFN- levels (results not
shown). Indeed, increased serum IFN- levels, reaching about
8,000 pg/ml, were already apparent on day 7 (i.e., during peak
parasitemia). A gradual reduction of these levels to about 500
pg/ml at day 28 was recorded during the chronic phase of the
infection, followed by a slight increase to about 1,500 pg/ml
towards the lethal endpoint of the infection. Most important,
however, was the finding that this serum IFN- pattern was not
affected by the absence or presence of LT-.
Anti-trypanosome immunoglobulin induction in the absence
of LT-. Antigenic variation of the major surface glycoprotein
VSG has been developed by trypanosomes as the main defense
strategy against the immune system of the mammalian host.
However, as VSG is a very immunogenic molecule, anti-VSG
antibodies are generated in both a T-cell-dependent and T-
cell-independent manner (33). Here, we have analyzed to what
extent mice that lack the LT- gene are capable of generating
an infection-induced anti-VSG response as well as a general
anti-trypanosome response as shown by endpoint titer deter-
mination. Figure 3 shows that in the sera of all infected mice,
significant titers of IgM, IgG2a, and IgG2b anti-trypanosome
antibodies could be detected. In contrast, IgG1 and IgG3 iso-
type antibody titers were found to be low and nonspecific in
general, showing endpoint titers between 1/10 and 1/20. In Fig.
3A, results of trypanosomosis-induced IgM endpoint titer de-
terminations on a VSG solid-phase coating are shown. From
these data, it is clear that specific antibodies are also generated
in the absence of LT-, following LT--independent kinetics
and reaching peak titers by day 14. However, the results also
show that the magnitude of the induced response is signifi-
cantly increased in the absence of LT-, reaching endpoint
titers of 1/25,600 compared to only 1/6,400 in WT mice. Figure
3B shows that the same trend is observed when measuring the
induction of specific anti-VSG IgG2a isotype titers. In this
case, maximum specific anti-VSG endpoint titers were mea-
sured by day 28, reaching 1/1,600 in the LT-/ mice com-
pared to 1/400 in the WT mice. Figure 3B also shows that, in
contrast to the IgM-IgG2a titers, the induction of anti-VSG
IgG2b isotype titers showed no difference between the two
strains and was significantly lower. In this case, maximum end-
point titers were measured by day 14 but only reached 1/100.
In addition to the determination of specific anti-VSG titers,
antibody induction against total trypanosome soluble-protein
extracts was analyzed as well. Figure 3C shows that, like the
VSG-specific titers, anti-trypanosome antibody titers also
reached significantly higher levels in the LT-/ mice than in
the WT mice. However, in contrast to the VSG-specific titers,
the titers shown kept rising during the course of infection,
reaching endpoint titers of 1/51,200 and 1/12,800 for the LT-
FIG. 2. Development of trypanosomosis-associated anemia in LT-
-deficient mice and control WT mice (A) and in LT-–TNF-double-
deficient as well as TNF-deficient mice (B). The values presented are
mean RBC counts  standard deviations, obtained from the same
mice as those used for the data presented in Fig. 1 and expressed as
percentages compared to mice before infection. p.i., postinfection.
Trypanosomosis-induced serum TNF levels (C) in both LT--deficient
mice and control WT mice were measured. Sera were collected on days
7, 14, and 28 and just prior to the lethal end of the infection. (), no
WT mice survived the infection as long as 55 days.
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/ and WT mice, respectively. Figure 3D shows the same
trend for the anti-trypanosome IgG2a titers. While endpoint
titers reached 1/1,600 towards the end of the infection in the
LT-/ mice, these titers remained between 1/400 and 1/800
during the chronic infection stage in WT mice. Again, no
difference in infection-induced IgG2b titers was observed be-
tween the LT-/ and WT mice, and titers of this antibody
isotype remained low throughout the infection.
Characteristics of experimental trypanosomosis develop-
ment in splenectomized mice. From the results discussed
above, it is clear that the capacity of LT-/ mice to control
trypanosomes is not hampered and that induction of anti-VSG
and anti-trypanosome antibodies is even more efficient than in
WT mice. Taking into account that LT-/ mice not only lack
peripheral lymph nodes but also lack splenic germinal centers,
the role of the spleen in trypanosomosis was further analyzed
in WT mice. To this end, 10 B6129SF2 WT mice were sple-
nectomized 6 weeks prior to infection with the pleomorphic
T. b. brucei AnTat 1.1E parasite. After infection, parasitemia,
survival, and development of anemia were recorded, as well as
the production of anti-VSG and anti-trypanosome antibodies.
As shown in Fig. 4A, no difference in the level of parasitemia
development or the induction of anemia occurred in the sple-
nectomized mice compared to the fully immune-competent
control mice (compare to Fig. 1A and 2A). Also, at the level of
survival, splenectomized mice did not show any accelerated
mortality, reaching a median survival time of 39 days compared
to 38 for the immune-competent WT mice (Fig. 1B). Finally,
also at the level of IgM and IgG2a and -2b antibody induction,
no alterations appeared to occur in the splenectomized mice
compared to control WT mice. This holds true both for anti-
VSG induction patterns (compare Fig. 4C and D and WT data
in Fig. 3A and B) and for general anti-trypanosome antibody
production (compare Fig. 4E and F and WT data in Fig. 3C
and D). Hence, during experimental T. b. brucei infections, the
efficient induction of anti-trypanosome antibodies occurs in the
absence of lymph nodes and splenic-germinal-center formation
and also in the complete absence of the spleen.
DISCUSSION
Though it is widely accepted that the main immune escape
mechanisms of African trypanosomes rely on antigenic varia-
tion of the variant-specific surface glycoprotein VSG (4), it is
known that the intensity of the trypanosomosis-induced anti-
body production by the host does not directly correlate with its
relative resistance or susceptibility. Indeed, when F1 mice are
generated using one resistant and one susceptible parental
mouse, it has been reported that while the antibody-inducing
capacity is inherited as a dominant trait, the survival capacity is
inherited from the susceptible mouse strain (8). As such, it is
FIG. 3. Infection-induced anti-VSG (A and B) and anti-trypano-
some (C and D) responses. Specific IgM (A) and IgG2a and -2b
(B) isotype serum endpoint titers were determined in a VSG solid-
phase ELISA system (0.2 g/well), using sera collected on days 7, 14,
and 28 and just prior to the lethal end of the infection. The same sera
were used to determine specific IgM (C) and IgG2a and -2b (D) iso-
type serum endpoint titers in an ELISA system that used total soluble
trypanosome extracts as a solid-phase coating (0.5 g/well).
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clear that besides anti-trypanosome antibody induction, other
factors contribute to resistance against trypanosome infections.
Most likely a complex cross talk between the host and the
parasite takes place in order to ensure optimal host survival
while allowing optimal parasite transmission. In this context, it
has been shown that apart from triggering antibody produc-
tion, trypanosomes cause several other immunological activi-
ties in their mammalian host, leading to the production of
FIG. 4. (A) Parasitemia development (left axis) and occurrence of trypanosomosis-associated anemia (RBC; right axis) in splenectomized
B6129SF2 mice. The parasitemia values presented are mean parasite counts (# Par.)/ml of blood  standard deviations. (B) Survival was followed
for five individual mice, and five other mice were sacrificed for serum collection on days 7, 14, 28, 36, and 40, respectively. (C and D) Infection-
induced specific anti-VSG IgM (C) and IgG2a and -2b (D) isotype serum endpoint titers were determined in a VSG solid-phase ELISA system
(0.2 g/well), using sera collected on days 7, 14, and 28 and just prior to the lethal end of the infection. (E and F) The same sera were used to
determine specific IgM (E) and IgG2a and -2b (F) isotype serum endpoint titers in an ELISA system that used total soluble trypanosome extracts
as a solid-phase coating (0.5 g/well).
1348 MAGEZ ET AL. INFECT. IMMUN.
 o
n
 M
ay 8, 2019 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
specific cytokines. Indeed, there is accumulating evidence that
rapid induction of a type 1 cytokine environment (IFN- and
TNF) is crucial for initial parasitemia control. It has been
reported that while resistant mice express a Th1 cell cytokine
response to VSG stimulation, susceptible mice do not (35).
Furthermore, using cytokine-deficient mouse models, it has
also been suggested that a type 1 cytokine response contributes
to trypanosomosis control. First, in IFN--deficient mice, ac-
celerated parasite growth and the lack of proper peak para-
sitemia control results in early death of the mice (13). Second,
in TNF-deficient mice, efficient control of peak parasitemia
levels is impaired, although survival time is not shortened (20).
In this case, we and others have reported that the effect of TNF
on peak parasitemia development is mediated by the direct
trypanolytic effect of the cytokine on the trypanosomes (6, 22).
The fact that this activity is mediated via the TIP sequence of
TNF, the domain that is responsible for the lectin-like activity
of the cytokine and that is able to specifically recognize the
conserved N-linked high-mannose moiety of the trypanosome
VSG, is important (19, 23). Interestingly, LT-, which is a
homologue of TNF with high amino acid sequence homology
(28), lacks trypanolytic activity and also lacks the TNF TIP
domain (19). Therefore, by using LT--deficient mice, we have
extended our study to the analysis of the role of LT- in the
control of experimental trypanosomosis and the induced im-
mune pathology. The results presented here show that, in con-
trast to TNF, LT- has no direct influence on parasite control.
It is interesting, however, that LT-/ mice show increased
anti-trypanosome IgM-IgG2a serum titers, coinciding with an
improved late-stage parasitemia control, while they lack signif-
icant IgG1, IgG2b, and IgG3 anti-trypanosome responses. It
should be emphasized that LT-/ mice do not have periph-
eral lymph nodes, do not generate splenic germinal centers
upon immune stimulation, and also lack the recruitment and
development of follicular dendritic cell networks (12) and nat-
ural killer cells in the spleen (39). It is important to stress that
it has never before been shown that efficient trypanosome
control can occur in the absence of lymph nodes. Thus, the
findings reported here are of particular interest, as in the past
a great deal of effort has gone into trying to unravel lymph
node-specific T. brucei-induced immunosuppression, as it was
thought that this phenomenon was important for the lack of
proper parasitemia control in mice and cattle (3). The results
presented here contradict this hypothesis, and as such, call for
renewed efforts to unravel host immune responses that are
crucial in the control of trypanosomosis. The limited impor-
tance of the spleen and splenic-germinal-center formation, on
the other hand, has been suggested by previous findings. In-
deed, in TNF/ mice that also lack splenic-germinal-center
formation, anti-trypanosome antibodies are formed as effi-
ciently as in WT mice (20). Furthermore, the data presented
here indicate that splenectomized mice also control experi-
mental African trypanosomosis in a way similar to that of
immune-competent littermates, further suggesting that the
spleen plays only a marginal role in control of the infection.
Finally, a case report of a splenectomized human trypanoso-
mosis patient also indicated that the lack of a functional spleen
does not alter disease progression (24). Hence, neither second-
ary lymphoid tissue nor germinal-center formation seems to be
required for the efficient generation of anti-trypanosome anti-
bodies in an infected host. This may be explained by previous
observations indicating that a large portion of the anti-trypano-
some IgM response, as well as the anti-VSG IgG2a antibody
response, is generated in a T-cell-independent manner (32).
Furthermore, it has been suggested that cross activation of
“self-reactive” responses (25, 26) together with polyclonal B-
cell activation (2) might trigger the development of humoral
anti-trypanosome responses. In this context, the fact that LT-
/ mice are characterized by a fourfold increase in circulat-
ing B cells should be taken into account as well (9). One
important feature of cross activation of B cells in human
trypanosomosis is the possible induction of autoimmune re-
sponses (11). However, the lack of increased pathology in the
LT-/ mice that do show increased levels of anti-trypano-
some antibody responses argues against the hypothesis that
this type of autoimmune complication is implemented in the
infection-associated pathology observed in mice. In fact, our
previous work and the results obtained here with TNF–LT--
double-deficient mice favors the suggested direct role of TNF
as a main mediator of trypanosomosis-associated pathology.
Indeed, it is only in mice that lack TNF that infection-associ-
ated anemia is controlled and the mice do not suffer from
severe overall morbidity. Interestingly, during the middle stage
of the infection in LT-/ mice (day 10 to day 28), anemia is
significantly less severe than in WT mice, a finding that can be
explained by the reduced TNF induction in LT-/ mice
during this stage. Moreover, it is clear from the results pre-
sented here that during the final stage of infection serum TNF
reaches the same levels in both LT-/ mice and WT mice,
and concomitantly, anemia occurs in the LT-/ mice as well.
In contrast to the lowered chronic-stage serum TNF levels in
the LT-/ mice, infection-induced IFN- levels appeared to
be normal throughout the infection. This finding could be
supported by previous reports that attribute both direct and
indirect trypanosomosis-associated IFN- secretion to CD8-
T-cell activation (31) and to the fact that circulating CD8-T-
cell numbers have been shown to be normal in LT-/ mice
(9).
In conclusion, the results presented in this study show that
the genetic deficiency of LT- that results in the lack of pe-
ripheral lymphoid tissue and germinal-center formation does
not hamper the control of experimental trypanosomosis. These
results certainly do not reflect a general infection resistance
phenotype characteristic of mice carrying an LT deficiency, as
it has been shown before that such mice have increased sus-
ceptibility to viral infections (17), as well as Mycobacterium and
Candida infections (15, 29). In the case of experimental Afri-
can trypanosomosis, improved infection resistance in the ab-
sence of LT- coincides with improved anti-trypanosome IgM
and IgG2a antibody responses, lower chronic-stage para-
sitemia levels, and prolonged survival. Although the increased
antibody titers themselves could be accounted for by a com-
bined effect of increased presence of circulating B cells in these
mice and a mechanism of T-cell-independent antibody gener-
ation and polyclonal B-cell activation, the results obtained
raise the intriguing and still-unanswered question of what the
mechanism is that results in the final parasitemia-controlling
potential of IgM and/or IgG2a isotype antibodies. At the level
of trypanosomosis-associated immune pathology, the results
presented confirm the key role of TNF. Indeed, while general
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pathology, and more particular anemia, is virtually absent in
both TNF/ and TNF/ LT-/ mice, it is also significantly
reduced in LT-/ mice during the middle infection stage
that is characterized by lowered circulating serum TNF levels.
However, the exact role of TNF in the functional cascade that
leads to trypanosomosis-induced RBC lysis remains to be elu-
cidated. Finally, data presented here show that in experimental
African trypanosome infections the combined genetic defi-
ciency of TNF/ and LT-/ gives rise to a phenotype that
is characterized by improved antibody-mediated chronic-stage
parasitemia control and the virtual absence of infection-asso-
ciated anemia and immunopathology, together resulting in a
significantly improved resistance to T. b. brucei infections.
However, even in TNF/ LT-/ mice, trypanosome growth
becomes uncontrolled after about 8 to 9 weeks of infection. So
far, nothing is known about the signals that trigger the induc-
tion of this final exponential growth phase of the parasite, and
further research will be needed to fully understand the immu-
nological interactions that mediate both host and parasite sur-
vival during African trypanosome infections.
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